Mabvax Therapeutics Holdings, Inc. (NASDAQOTH:TELKD)

CAPS Rating: 1 out of 5

A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.

Recs

0
Player Avatar pchop123 (79.78) Submitted: 2/22/2013 1:39:49 PM : Outperform Start Price: $1.72 TELKD Score: -4.00

good entry point

Featured Broker Partners


Advertisement